Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. Pulse Charter Connect
Pulse Charter Connect is a Chicago-based company founded in 2022 that offers a digital SaaS platform designed to optimize organ transportation logistics. By automating and streamlining the coordination between transplant centers and charter operators, the platform aims to enhance organ transplant success rates through faster, safer, and more cost-effective transportation.
- Sector: Healthcare Technology / MedTech / Digital Health (SaaS)
- Last known transaction date: Seed Venture, $2M, May 2025
- Why timing suggests a near-term transaction: The company just closed a seed round co-led by Ivy Ventures and Simplex Ventures in May 2025, with strategic participation from Cedars Sinai Health Ventures and Techstars. Post-seed companies typically raise a Series A within 12–24 months of closing seed funding, putting PCC squarely in a likely near-term fundraise window in 2026–2027. The oversubscribed nature of the round signals strong investor interest, and their stated use of proceeds (scaling operations, enhancing software, expanding national footprint) points to rapid growth that will likely require additional capital soon.
View all private company data in Dakota Marketplace.
2. Tesseral
Tesseral is a San Francisco–based technology company founded in 2023 that provides open-source authentication infrastructure for B2B software applications. Its platform enables developers to implement identity, access management, and API security features with minimal integration effort.
- Sector: Health Care
- Last known transaction date: Seed Venture, $3.3M, May 2025
- Why timing suggests a near-term transaction: Tesseral’s $3.3M seed round announced in May 2025 places the company approximately 12–18 months removed from its initial financing by mid to late 2026, aligning with the typical window when seed-stage companies begin preparing for their next raise. As product development, early customer traction, and market validation progress, the company is likely to evaluate follow-on capital, strategic partnerships, or early acquisition interest.
View all private company data in Dakota Marketplace.
3. PhaseV
PhaseV is a Boston-based company founded in 2023 that offers AI-driven solutions to enhance clinical development and operations for biopharma sponsors and contract research organizations (CROs). By leveraging machine learning, PhaseV streamlines processes such as feasibility assessments and site selection, enabling data-driven decisions that accelerate trial timelines.
- Sector: Healthcare Technology / AI/ML / Clinical Development (SaaS)
- Last known funding round: Series A, $50M, May 2025 (total raised to date: $65M; co-led by Accel and Insight Partners)
- Why timing suggests a near-term transaction: PhaseV closed a $50M Series A in May 2025 with top-tier institutional VCs (Accel and Insight Partners), which typically signals an aggressive growth phase. Companies at this stage with strong revenue traction (30+ global pharma/biotech customers) and blue-chip backers generally pursue a Series B within 18–24 months, putting PhaseV in a likely fundraise window in late 2026 to mid-2027. The stated use of proceeds, scaling operations and expanding their customer base in pharma, biotech, and CROs, suggests capital will be deployed quickly, accelerating the need for follow-on funding.
View all private company data in Dakota Marketplace.
4. Ousia Pharma
Ousia Pharma is a Denmark-based biotechnology company founded in 2022 that develops therapies for cardiometabolic diseases. Its research focuses on peptide-drug conjugates targeting appetite regulation pathways in the brain.
- Sector: Health Care
- Last known funding round: Seed Venture, Undisclosed, May 2025
- Why timing suggests a near-term transaction: Ousia Pharma’s seed round announced in May 2025 places the company approximately 12–18 months removed from its initial financing by mid to late 2026, aligning with the typical window when seed-stage biotechnology companies begin preparing for their next raise. As preclinical development, pipeline validation, and strategic research partnerships advance, the company is likely to evaluate follow-on capital, strategic biopharma investment, or early acquisition interest.
View all private company data in Dakota Marketplace.
5. ArborXR
ArborXR is a technology company founded in 2016 that provides device management and content deployment software for virtual and augmented reality systems. Its platform enables enterprises to manage XR devices, distribute applications, and control user experiences at scale.
- Sector: Information Technology
- Last known funding round: Strategic Acquisition, Undisclosed, May 2025
- Why timing suggests a near-term transaction: ArborXR’s strategic acquisition announced in May 2025 places the company in the early phase following a significant strategic event. At this stage, platforms often remain active in additional M&A, strategic partnerships, or capital raises, as integration progress, product expansion, and market positioning create opportunities for further transaction activity.
View all private company data in Dakota Marketplace.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
